Peregrine Pharmaceuticals Inc (PPHM.OQ)

PPHM.OQ on NASDAQ Stock Exchange Capital Market

1.48USD
25 Nov 2014
Price Change (% chg)

$0.02 (+1.37%)
Prev Close
$1.46
Open
$1.46
Day's High
$1.50
Day's Low
$1.45
Volume
89,838
Avg. Vol
232,110
52-wk High
$3.18
52-wk Low
$1.25

PPHM.OQ

Chart for PPHM.OQ

About

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of monoclonal antibodies in clinical trials for the treatment and diagnosis of cancer. The Company has two platforms and are pursuing multiple clinical programs in cancer with its lead immunotherapy candidate bavituximab, its PS-targeting agent,... (more)

Overall

Beta: 1.34
Market Cap (Mil.): $262.08
Shares Outstanding (Mil.): 179.51
Dividend: --
Yield (%): --

Financials

  PPHM.OQ Industry Sector
P/E (TTM): -- 38.28 39.18
EPS (TTM): -0.25 -- --
ROI: -81.99 17.89 17.24
ROE: -86.25 18.63 18.11
Search Stocks

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks